RNS Number : 1734R
Abingdon Health PLC
25 October 2023
 

Abingdon Health plc

("Abingdon Health" or the "Company")

 

Director Dealing

 

York, U.K. 25 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests announces that on the 24th October 2023, Dr Chris Hand, Non-Executive Chairman purchased ordinary shares of 0.025 pence each in the Company ("Ordinary Shares").

 

Further details are as follows:

 

Director

No. Ordinary Shares Purchased

Aggregate Purchase Price

(Pence per Ordinary Share)

Enlarged Holding

(No. Ordinary Shares)

Enlarged Holding*

(Per cent. of Total Voting Rights)

Dr Chris Hand

150,000

10.167

13,178,467

10.83%

*Excluding options over Ordinary Shares

 

The Notification of Dealing Form required in accordance with UK MAR is set out below.

 

Enquiries:

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Chris Hand, Non-Executive Chairman

 

 

 

 

 

Singer Capital Markets (Sole Broker and Nominated Adviser)

Tel: +44 (0)20 7496 3000

Peter Steel, Alex Bond, Jalini Kalaravy

 


 


 

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com

Paul McManus, Phillip Marriage,

Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082

+44 (0)7407 804 654

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dr Chris Hand

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 



Identification code

GB00BLF79J41



b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

 

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




10 pence per share

10.5 pence per share

100,000

50,000







d)

 

Aggregated information




- Aggregated volume

150,000



- Price

10.167 pence per share



e)

 

Date of the transaction

 

 

24th October 2023

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 

About Abingdon Health plc

 

Abingdon Health is a leading lateral flow contract research ("CRO") and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

 

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. 

 

Abingdon Health's Abingdon Simply Test? range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test? ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZLFLXBLFFBB